It is clinically implicated that hyperinsulinemia or diabetes could be one of the risk factors inducing breast cancers and that the active insulin pathway could also facilitate the progression and metastasis of breast cancer via providing excessive nutrients and pro-survival signals [36,37]. The gene discussed is INS; the disease is diabetes mellitus.